[ad_1]
Farid Uddin Ahmed
First page Friday, October 2, 2020
The coronavirus vaccine has been working indefinitely from the beginning. There was a dilemma among some people about whether they should get vaccinated or not. However, the decision to vaccinate came later after anticipating the severity of the Corona epidemic. But the vaccine will be taken from any organization. As there is no roadmap on how the vaccine will arrive, nothing can be said for sure yet. The Chinese company Synovac had long proposed to test its coronavac vaccine in Bangladesh. According to the proposal, the test of this ticker would be free in the country. Also, if the vaccine were effective, a certain number of doses would be available for free. But this opportunity has been lost due to various pressures. Synovac now says that Bangladesh will have to spend money to run its test in Bangladesh. Because the money they had earmarked for the ticker test has already been invested in different countries. Concerned parties say that this situation has been created due to indecision about the judgment. This opportunity has been lost due to the negligence of those concerned. Some say the opportunity was missed and there was a lot of pressure and geopolitics. For these reasons, the interested party was unable to make a decision in time. He suffered from hesitation. This situation has been created by going to the accounting fair.
Although the Ministry of Health says that the Sinovac trial will take place in Bangladesh. And they hope that the next cabinet meeting will decide on these issues.
In a letter about the trial, Sinovac said the funding for the trial was in Bangladesh. But since Bangladesh has been slow to make a decision and other countries have received “earmarked funds” for the trials. So they have requested financial assistance from Bangladesh. Secretary of the Department of Health. In this regard, said Abdul Mannan, Sinovac wants economic cooperation from Bangladesh. We have not made any decisions yet. However, Sinovac said that even if Bangladesh does not co-finance, it will hold a trial, in which case it will take time. A delegation of them will come next month, and after their survey this month, Sinovac can decide. The secretary said that all of Sinovac’s conditions have been sent to the prime minister and that the decision will be made at the cabinet meeting next week.
On July 17, the Bangladesh Medical Research Council (BMRC) approved the vaccine for trial in Bangladesh. Through ICDDR’B, they requested a third test phase in this country. Then it took more than a month to get permission for the Sinovac trial. The National Technical Advisory Committee on Covid-19 has also discussed a vaccine trial in the country more than once. The expert advisory committee has also recommended advance booking of vaccines.
Health Minister Zahid Malek said yesterday in a function at the Health Ministry that the government has taken appropriate measures to obtain the coronavirus vaccine at the right time. “We want the whole world, including Bangladesh, to be freed from Kovid,” he said. You need a vaccine. That is why we have taken the appropriate measures. We have taken steps to get the vaccine at the right time.
Bangladesh hopes to obtain 34 million doses of vaccine through the World Health Organization. There is virtually no action plan on where the remaining 140 million people will be vaccinated. However, some countries in the world have already ordered 5 times more vaccines than their population. Even if you get vaccinated through HU in Bangladesh, it will come in some stages. It will take a long time. In the first phase, they will receive 51 lakhs of vaccines. It will first be available at a rate of 3 percent of the country’s population. Those who are older (over 60 years) and suffer from comorbidity (complex diseases) will receive the vaccine as a priority. Bangladesh sent a letter to the World Health Organization on July 9 to receive the vaccine. The total number of vaccines mentioned as 20 percent will arrive in the country. If you want to know about the corona vaccine, the line director of the vaccination program, Dr. Mohammad Shamsul Haque said that poor and middle-income countries would receive the vaccine at a rate of 20 percent. The vaccine is expected to be available in mid-2021 if the vaccine is produced in December. It all depends on the production of vaccines. When asked if 20 percent of the vaccine would be available for free, he said it would come as co-financing. The issue was discussed at a meeting of the board of directors of the international Gavi vaccine alliance on September 30. It will take time to know the final. He added that it was not immediately clear where the vaccines would come from for the remaining 140 million people. He also mentioned that the government is contacting for this.
[ad_2]